← Back to Search

JoyRise Recovery Powder for Cognitive Impairment

N/A
Waitlist Available
Research Sponsored by Joyrise
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 30 minutes after product consumption on the day following alcohol consumption.
Awards & highlights

Summary

This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants will be randomly assigned to either the JoyRise group or a placebo group. The study will measure hangover symptoms, cognitive function, and overall well-being through a series of questionnaires and cognitive tests at baseline, 30 minutes after product consumption, and 4 hours later.

Eligible Conditions
  • Hangover
  • Cognitive Impairment
  • Anxiety

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 30 minutes after product consumption on the day following alcohol consumption.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 30 minutes after product consumption on the day following alcohol consumption. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reduction in Symptoms Associated with Alcohol Aftereffects
Secondary study objectives
Improvement in Cognitive Function
Increased User Satisfaction with Overall Well-being
Reduction in Feelings of Anxiousness

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: JoyRise Recovery PowderExperimental Treatment1 Intervention
Participants in this arm will receive JoyRise Recovery Powder, a dietary supplement containing Dihydromyricetin (DHM) and other natural ingredients.
Group II: PlaceboPlacebo Group1 Intervention
Participants in this arm will receive a placebo solution that is visually and tastefully similar to the JoyRise Recovery Powder but contains no active ingredients.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
JoyRise Recovery Powder
2024
N/A
~60

Find a Location

Who is running the clinical trial?

JoyriseLead Sponsor
CitruslabsIndustry Sponsor
87 Previous Clinical Trials
4,590 Total Patients Enrolled
~40 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top